首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis.
【24h】

A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis.

机译:TCR接触残基的连续取代的三重改变的胶原蛋白II肽抑制胶原蛋白诱发的关节炎。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The collagen type II (CII) 263-272 peptide is a predominant T and B cell antigenic peptide in rheumatoid arthritis. Crystallographic data showed that 263F and 264K of CII263-272 are mainly responsible for binding with HLA-DR, and that 267Q and 270K were the major T cell Teceptor (TCR)-contact residues. We have shown that the CII altered peptide ligand JAPL) with individual or consecutive substitutions of the TCR-contact amino acids could inhibit T cell activation induced by wild-type CII peptide in the context of HIA-DRB1, among which the most potent T cell activation suppressor is sub268-270, in which the amino acids of wild-type CII263-272 at positions 268, 269 and 270 were substituted with glycine or alanine (FKGEQAGAGE, substitutions underlined). Collagen-induced arthritis (CIA) is induced by wild-type CII in susceptible rodent strains. It has been regarded as the best rheumatoid arthritis model.
机译:II型胶原(CII)263-272肽是类风湿关节炎的主要T和B细胞抗原肽。晶体学数据表明,CII263-272的263F和264K主要与HLA-DR结合,而267Q和270K是主要的T细胞受体(TCR)接触残基。我们已经表明,在HIA-DRB1的背景下,具有TCR接触氨基酸的单个或连续替换的CII改变的肽配体JAPL)可以抑制野生型CII肽诱导的T细胞活化,其中最有效的T细胞激活抑制剂是sub268-270,其中野生型CII263-272的268、269和270位氨基酸被甘氨酸或丙氨酸取代(FKGEQAGAGE,带下划线的取代)。胶原诱导的关节炎(CIA)由易感啮齿动物品系中的野生型CII诱导。它被认为是最好的类风湿关节炎模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号